$1.82
0.55% yesterday
Nasdaq, May 20, 10:00 pm CET
ISIN
US05479K1060
Symbol
ELUT
Sector
Industry

Aziyo Biologics Inc - Ordinary Shares - Class A Stock price

$1.82
-0.48 20.87% 1M
-2.56 58.45% 6M
-1.92 51.34% YTD
-1.54 45.84% 1Y
-4.38 70.65% 3Y
-15.18 89.29% 5Y
-15.18 89.29% 10Y
Nasdaq, Closing price Tue, May 20 2025
+0.01 0.55%
ISIN
US05479K1060
Symbol
ELUT
Sector
Industry

Key metrics

Market capitalization $74.83m
Enterprise Value $92.72m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 3.91
P/S ratio (TTM) P/S ratio 3.16
P/B ratio (TTM) P/B ratio negative
Revenue growth (TTM) Revenue growth -18.22%
Revenue (TTM) Revenue $23.71m
EBIT (operating result TTM) EBIT $-22.94m
Free Cash Flow (TTM) Free Cash Flow $-29.81m
Cash position $17.36m
EPS (TTM) EPS $-1.94
P/E forward negative
P/S forward 2.61
EV/Sales forward 3.23
Short interest 0.34%
Show more

Is Aziyo Biologics Inc - Ordinary Shares - Class A a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.

Aziyo Biologics Inc - Ordinary Shares - Class A Stock Analysis

Unlock Scores for Free

Analyst Opinions

2 Analysts have issued a Aziyo Biologics Inc - Ordinary Shares - Class A forecast:

2x Buy
100%

Analyst Opinions

2 Analysts have issued a Aziyo Biologics Inc - Ordinary Shares - Class A forecast:

Buy
100%

Financial data from Aziyo Biologics Inc - Ordinary Shares - Class A

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
24 24
18% 18%
100%
- Direct Costs 13 13
34% 34%
56%
10 10
17% 17%
44%
- Selling and Administrative Expenses 26 26
8% 8%
111%
- Research and Development Expense 3.52 3.52
18% 18%
15%
-19 -19
2% 2%
-82%
- Depreciation and Amortization 3.46 3.46
5% 5%
15%
EBIT (Operating Income) EBIT -23 -23
3% 3%
-97%
Net Profit -40 -40
25% 25%
-169%

In millions USD.

Don't miss a Thing! We will send you all news about Aziyo Biologics Inc - Ordinary Shares - Class A directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Aziyo Biologics Inc - Ordinary Shares - Class A Stock News

Neutral
Seeking Alpha
10 days ago
Elutia Inc. (NASDAQ:ELUT ) Q1 2025 Earnings Conference Call May 8, 2025 5:00 PM ET Company Participants Matt Steinberg - FINN Partners Randal Mills - Chief Executive Officer Matt Ferguson - Chief Financial Officer Conference Call Participants Frank Takkinen - Lake Street Capital Matt Park - Cantor Fitzgerald Operator Good afternoon, ladies and gentlemen. Welcome to the Elutia First Quarter 2025...
Neutral
GlobeNewsWire
12 days ago
- New Boston Scientific distribution partnership now underway - - Conference call today at 5:00 p.m. ET / 2:00 p.m.
Neutral
GlobeNewsWire
19 days ago
Move expected to drive both top-line growth and gross margin improvement SILVER SPRING, Md., May 01, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix products, today announced it is reclaiming U.S. sales and distribution responsibilities for its cardiovascular portfolio—including ProxiCor®, VasCure®, and Tyke®—following the con...
More Aziyo Biologics Inc - Ordinary Shares - Class A News

Company Profile

Aziyo Biologics, Inc. operates as a biotechnology company which focuses on regenerative medicine in areas such as cardiology, orthopedics and other medical specialties. It offers cardiac device envelope, vascular surgery, cardiothoracic repair, orthopedics and spine, sports medicine, dermal, and wound care. The company was founded on August 6, 2015 and is headquartered in Silver Spring, MD.

Head office United States
CEO Charles Mills
Employees 51
Founded 2015
Website www.elutia.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today